The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology
- 1 May 1984
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 18 (1) , 18-27
- https://doi.org/10.1016/0090-8258(84)90002-7
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Initial pharmacology and toxicology of intravenous desmethylmisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer:Rationale and resultsCancer, 1982
- SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical useInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Is tumour radiosensitization by misonidazole a general phenomenon?British Journal of Cancer, 1980
- Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenationThe British Journal of Radiology, 1979
- Endometrial carcinoma:Causes of death and sites of treatment failureCancer, 1979
- Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervixThe British Journal of Radiology, 1978
- A simplification in the use of the NSD concept in practical radiotherapyThe British Journal of Radiology, 1973
- Primary carcinoma of the vaginaAmerican Journal of Obstetrics and Gynecology, 1970
- Causes, Time of Death, and Sites of Failure in Squamous-Cell Carcinoma of the Uterine Cervix on Intact UterusRadiology, 1967